Background The rationale behind this update on the 2016 British Society for Rheumatology
(BSR) guidelines on prescribing anti-rheumatic drugs in pregnancy and breastfeeding [1, 2] …

Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by
thrombosis and pregnancy morbidity with the persistent presence of antiphospholipid …

Background People with inflammatory or autoimmune diseases are recommended to
continue immunomodulatory biologic agents throughout pregnancy. However, concerns …

This article is published as part of a supplement sponsored by Kidney Disease: Improving
Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of …

6 US Food & Drug Administration. Biosimilar product information. May 25, 2023. https://www.
fda. gov/drugs/biosimilars/biosimilar-productinformation (accessed July 24, 2023). 7 Emery …

Abstract Introduction and Objective The risks and benefits of medication use in pregnancy
are typically established through post-marketing observational studies. As there is currently …

Immune thrombocytopenia (ITP) is a rare autoimmune condition, due to peripheral platelet
destruction through antibody-dependent cellular phagocytosis, complement-dependent …

Rheumatic and musculoskeletal diseases often affect individuals of childbearing age. The
incidence and prevalence of rheumatic and musculoskeletal diseases is rising. More …

Maternal autoimmune rheumatic diseases can influence the outcomes of children through
several life stages. During pregnancy, maternal inflammation and autoantibodies can hinder …

Uncontrolled asthma is associated with an increased risk of adverse perinatal outcomes.
Asthma biologics reduce exacerbation frequency, are steroid sparing, and improve quality of …